Experiment 510308
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | SCHEID,C: PRENDIVILLE,J: JAYSON,G: CROWTHER,D: FOX,B: PETTIT,GR: STERN,PL:. (1994). IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN 1 IN A PHASE I CLINICAL STUDY: COMPARISON WITH EFFECTS OF BRYOSTATIN 1 ON LYMPHOCYTE FUNCTION IN VITRO.. 39(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I STUDY OF EFICACY OF CMPD IN TREATING CANCER IN 7 PATIENTS, 5 HAVING OVARIAN CA, ONE EACH WITH MELANOMA AND SARCOMA. IL-2-INDUCED LAK ACTIVITY AND PROLIFERATION WERE INCREASED. |
| Dose amount | 35.0 MCG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |